<DOC>
	<DOCNO>NCT00703196</DOCNO>
	<brief_summary>RATIONALE : Supplements , folic acid , may stop delay development cervical cancer woman infect human papillomavirus . PURPOSE : This phase II trial study well folic acid supplement work prevent cancer woman infect human papillomavirus .</brief_summary>
	<brief_title>Folic Acid Clinical Trial Prevention Cervical Cancer</brief_title>
	<detailed_description>OBJECTIVES : Primary - Evaluate effect folic acid supplementation clearance human papilloma virus ( HPV ) 16 specific type HR-HPV prevention progression ≤ cervical intraepithelial neoplasia ( CIN ) 1 lesion ( true preneoplastic lesion ) CIN ≥ 2 ( true neoplastic lesion ) conduct 12-month double-blind randomize placebo-controlled trial 5 mg folic acid/day . Secondary - Evaluate whether clearance HPV 16 specific HR-HPV type progression cervical lesion ( ≤ CIN 1 CIN ≥ 2 ) modify low level circulate and/or cervical cell folate , presence micronuclei global DNA hypomethylation cervical cell , presence integrate vs episomal HPV 16 , high HPV 16 viral load cervical cell enrollment . OUTLINE : This single center study . Patients stratify accord multivitamin use ( yes v ) smoking status ( smoker v nonsmoker ) . Patients randomize 1 2 treatment arm . - Arm I : Patients receive oral folic acid pill daily 12 month absence unacceptable toxicity adverse effect . - Arm II : Patients receive oral placebo daily 12 month absence unacceptable toxicity adverse effect . All patient complete diet , physical activity , risk factor questionnaire enrollment visit ( 0-month ) 4 , 8 , 12 month visit ( total 4 visit ) . Fasting blood sample assess circulate concentration micronutrient ( folate , vitamins B12 , A , E , C , total carotene ) exfoliate cervical cell sample assess HPV collect 4 visit . Anthropometric measure take study visit . A colposcopically direct biopsy take 0-month visit 12-month visit assess histological diagnosis cervical lesion .</detailed_description>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Precancerous Conditions</mesh_term>
	<mesh_term>Folic Acid</mesh_term>
	<mesh_term>Vitamin B Complex</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Received care Health Departments Alabama abnormal pap result , include follow : Atypical squamous cell undetermined significance ( ASCUS ) ASCUS , exclude highgrade lesion ( ASCUSH ) Lowgrade squamous intraepithelial lesion Highgrade squamous intraepithelial lesion Referred University Alabama Birmingham ( UAB ) Highlands Clinic colposcopic examination Ob/Gyn physician Tested positive human papilloma virus ( HPV ) 16 diagnosed ≤ cervical intraepithelial neoplasia ( CIN ) 1 lesion 0month visit With without concurrent infection HR ( High Risk ) HPV type ( HPV 18 , 31 , 33 , 35 , 39 , 45 , 51 , 52 , 56 , 58 , 59 , 68 ) Not diagnose true preneoplastic lesion cervix base colposcopically direct biopsy PATIENT CHARACTERISTICS : Not pregnant Willing take study pill , keep schedule followup study visit , communicate study personnel change contact information study period No prior diagnosis treatment colon polyp breast lumps PRIOR CONCURRENT THERAPY : No prior treatment cervical cancer precancerous condition No prior surgery involve cervix No concurrent antifolate medication methotrexate , sulfasalazine phenytoin No concurrent plan consumption 400 μg folic acid supplement regular basis Not involved clinical trial</criteria>
	<gender>Female</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>120 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>cervical cancer</keyword>
	<keyword>human papilloma virus infection</keyword>
	<keyword>low-grade squamous intraepithelial lesion</keyword>
	<keyword>high-grade squamous intraepithelial lesion</keyword>
	<keyword>atypical squamous cell undetermined significance</keyword>
	<keyword>cervical intraepithelial neoplasia grade 1</keyword>
	<keyword>cervical intraepithelial neoplasia grade 2</keyword>
	<keyword>cervical intraepithelial neoplasia grade 3</keyword>
</DOC>